Philipp Harter
Papers
2
Total Citations
54
H-Index
2
About
Dr. Philipp Harter is a leading gynecologic oncologist whose research focuses on precision medicine in ovarian cancer and the optimization of surgical approaches for gynecologic malignancies. His most impactful contribution lies in the clinical validation of homologous recombination deficiency (HRD) as a critical biomarker for targeted therapy. In his landmark 2022 study, cited over 40 times, Dr. Harter demonstrated the feasibility and clinical utility of HRD testing in a real-world cohort of 514 ovarian carcinoma patients, using next-generation sequencing to identify BRCA1/BRCA2 mutations and genomic instability. This work has been instrumental in defining which patients may benefit from PARP inhibitors, directly shaping treatment guidelines. Additionally, Dr. Harter has advanced surgical care by investigating the implementation of robot-assisted gynecologic surgery across diverse patient populations, including those with low and high BMI. His 2014 study on this topic, with 14 citations, provided crucial data on the safety and efficacy of minimally invasive techniques in a German cancer center. Through these contributions, Dr. Harter bridges molecular diagnostics and surgical innovation, improving outcomes for women with gynecologic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2